Bayer's stock price surges 12% following a significant legal victory in the United States against claims linking Roundup to cancer.
Bayer's shares rose in early trading after the company announced a legal victory in its lawsuit against allegations that Roundup weed killer exposure caused cancer.
The stock was up 11.67% at 11:44 a.m. London time.
On Thursday, the 3rd U.S. Circuit Court of Appeals in Philadelphia ruled in favor of the company against plaintiff David Schaffner's claim that Bayer, which acquired Monsanto in 2018, violated state law by not adding a cancer warning to the Roundup label.
This breaking news story is being updated.
Markets
You might also like
- Delinquencies are on the rise while a record number of consumers are making minimum credit card payments.
- U.S. economy state weighs on little changed treasury yields.
- European markets predicted to sustain positive growth.
- Trump hints at imposing a 10% tariff on China starting in February.
- David Einhorn believes we are currently in the "Fartcoin" phase of the market cycle.